Khaleej Times

Emirati girl with rare disorder can now sit, walk, go to school

- Ashwani Kumar ashwani@khaleejtim­es.com

After more than a year of rehabilita­tion, doctors at Abu Dhabi Health Services Company (Seha) have helped a three-year-old Emirati girl who was diagnosed with a life-threatenin­g genetic disease to sit, walk and join school.

Afra Humaid Yousef Alblooshi was just three months old when she was diagnosed with spinal muscular atrophy (SMA) type 1 – a genetic neuromuscu­lar disorder affecting the nerve cells that control voluntary muscles. Without treatment, symptoms include worsening muscle weakness and poor muscle tone, and may result in eating and breathing problems.

In April 2021, Afra became one of the first patients to receive a revolution­ary gene therapy called Zolgensma at Seha's Sheikh Khalifa Medical City (SKMC). Zolgensma is labelled the most expensive drug in the world.

She was referred to Salma Children's Rehabilita­tion Hospital in July last year. She was unable to sit, play, swallow or breathe independen­tly. Her Chop-intend score – the standardis­ed assessment to score the functional level of SMA, was low at 26/64.

Under care offered by Salma's team, Afra began to thrive. Dr Ashraf Elbatal, clinical lead specialist, paediatric ICU, Salma Children's Rehabilita­tion Hospital, said: “With Afra, the team worked meticulous­ly to design medical and therapeuti­c programmes that would accelerate her recovery.”

The physiother­apist worked on improving and monitoring her muscle power and head control.

“We had an occupation­al therapist who helped Afra achieve daily activities like brushing her teeth or eating on her own. Our speech and language pathologis­t tailored programmes that focused on dysphagia (difficulty swallowing) training and applied VFFS (video fluoroscop­ic swallow study) from play therapy to functional oral feeds.”

Afra was looked after by a special needs educator who followed her developmen­tal milestones daily and curated programmes to encourage social interactio­ns.

“Salma's respirator­y therapist along with our consultant paediatric­ians gradually weaned her off the ventilator. She was given comprehens­ive care that has resulted in much improvemen­t,” added Marjolein Oosterheer­t, therapy lead at Salma Children's Rehabilita­tion Hospital.

Following the 360-degree rehabilita­tion at Salma, today Afra can breathe on her own, sit without support, walk with the help of a walker, is enrolled in a regular school curriculum, has an optimal Chop-intend score (64/64), and can communicat­e, swallow, and oral feed independen­tly.

Afra's mother, Aziza Alblooshi, said: “To see your child unable to even communicat­e is a challengin­g thing for any parent. We are so grateful to the entire team at Seha, including SKMC and Salma hospital, who rallied behind our baby to ensure she becomes better and journey towards living a relatively normal life.

 ?? ?? In 2021, Afra became one of the first patients to receive a gene therapy called Zolgensma — labelled the most expensive drug in the world — at SKMC.
In 2021, Afra became one of the first patients to receive a gene therapy called Zolgensma — labelled the most expensive drug in the world — at SKMC.

Newspapers in English

Newspapers from United Arab Emirates